Company: REVB
Filing Date: 2025-06-25
Form Type: 8-K
Source: 0000950170-25-089972
Chunk: 3

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-06-25
Form: 8-K
Item: Item 8.01
Chunk 3
---
Item 8.01.

Other Information.

At the conclusion of the meeting, James Rolke, the Company’s CEO, provided a brief presentation regarding recent corporate updates and project developments. A copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The presentation has also been posted on the Company’s website.

The information in this Item 8.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.